Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9670|25|4|400-410

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.25, Iss.4, 2005-08, pp. : 400-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study

By  

Blood Purification, Vol. 43, Iss. 4, 2017-03 ,pp. : 338-345

Karger

Access to resources Recommend Favorite

Delirium in Patients on Hemodialysis Therapy

By  

Nephron, Vol. 90, Iss. 2, 2002-01 ,pp. : 236-236

Karger

Access to resources Recommend Favorite

Vitamin B6 Therapy Does Not Improve Hematocrit in Hemodialysis Patients Supplemented with Iron and Erythropoietin

By  

Nephron, Vol. 87, Iss. 4, 2001-03 ,pp. : 328-332

Karger

Access to resources Recommend Favorite

Screening and Study Enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial

By  

Blood Purification, Vol. 27, Iss. 2, 2009-01 ,pp. : 199-205

Karger

Access to resources Recommend Favorite

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin: 1-Year Follow-Up Study

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 200-201

Karger

Access to resources Recommend Favorite